Cerebral haemodynamics in preterm infants after exposure to dexamethasone

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 2, 1998, Pages

  Pellicer, Adelina ^a   Gayá, Francisco ^a   Stiris, Tom A ^b   Quero, José ^a   Cabañas, Fernando ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebral haemodynamics; Dexamethasone; Near infrared spectroscopy

Indexed keywords

CARBON DIOXIDE; DEXAMETHASONE;

ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EXTUBATION; FEMALE; HUMAN; INFANT; INFRARED SPECTROSCOPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; TRANSCUTANEOUS CARBON DIOXIDE MONITORING;

EID: 0031656902     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.2.F123     Document Type: Article

References (39)

1. Avery GB, Fletcher AB, Kaplan M, Brudno DS . Controlled trial of dexamethasone in respiretor-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106-11.
2. Collaborative Dexamethasone Trial Group . Dexamethasone therapy in neonatal crhonic lung disease: an international placebo-controlled trial. Pediatrics 1991;88:421-7.
3. Cummings JJ, D'Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 1989;320:1505-10.
4. Mammel MC, Green TP, Johnson DE, Thompson TR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1983;i:1356-8.
5. Rastogi A, Morales P, Akintori S, Bez M, David R, Pildes RS. Randomized double blind trial of dexamethasone (D) plus surfactant (S) for prevention of BPD. Pediatr Res 1994;35:250A.
6. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 1990;117:273-82.
7. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993;68:330-6.
8. Stiris TA, Garcia-Alix A, Blanco D, Cabañas F, Pellicer A, Quero J. The response of total and regional blood flow to dexamethasone (DEX) infusion in newborn piglets during normoxia. Pediatr Res 1994;35:269A.
9. Stiris TA, Blanco D, Codoceo R, et al. Effects of dexamethasone on retinal and choroidal blood flow during normoxia and hyperoxia in newborn piglets. Pediatr Res 1996;40:592-6.
10. Cabañas F, Pellicer A, Garcia-Alix A, Quero J, Stiris TA. Effect of dexamethasone therapy on cerebral and ocular blood flow velocity in premature infants studied by colour Doppler flow imaging. Eur J Pediatr 1997;156:41-6.
11. Jobsis FF. Noninvasive infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977;198:1264-7.
12. Wray S, Cope M, Delpt DT, Wyatt JS, Reynolds EOR. Characterisation of the near infrered absorption spectra of cytochrome aa3 and haemoglobine for non-invasive monitoring of cerebral oxygenation. Biochim Byiophys Acta 1988;933:184-92.
13. Essenpries M, Cope M, Elwell CE, Arridge SR, van de Zee P, Delpy DT. Wavelength dependence of the differential pathlength factor and the long slope in the time resolved tissue spectroscopy. In: Dirnagl U, ed. Optical Imaging of Brain Function and Metabolism. New York:Plenum Press, 1993: 9-20.
14. Thorniley MS, Lane NJ, Manek S, Green CJ. Noninvasive measurement of respiratory chain dysfunction following hypothermic renal storage and transplantation. Kidney Int 1994; 45:1489-96.
15. Wyatt JS, Cope M, Delpy DT. Measurement of optical pathlength for cerebral near-infrared spectroscopy in newborn infants. Dev Neurosci 1990;12:140-4.
16. Wyatt JS, Edwards AD, Cope M, et al. Response of cerebral blood volume to changes in arterial carbon dioxide tension in preterm and term infants. Pediatr Res 1991;29:553-7.
17. Lammertsma AA, Brooks DJ, Bearney RP . In vivo measurement of regional cerebral hemotocrit using possitron emission tomography. J Cereb Blood Flow Metab 1984;4:317-22.
18. Wyatt JS, Cope M, Delpy DT, et al. Quantitation of cerebral blood volume in human infants by near-infrared spectroscopy. J Apply Physiol 1990;68:1086-91.
19. Edwards AD, Wyatt JS, Richardson D, Delpy DT, Cope M, Reynolds EOR. Cotside measurement of cerebral blood flow in ill preterm infants by near-infrared spectroscopy. Lancet 1988; ii:770-1.
20. Edwards AD, Wyatt JS, Richardson CE, Delpy DT, Cope M, Reynolds EOR. Precision of cerebral blood flow (CBF) measurements by near-infrared spectroscopy (NIRS). Pediatr Res 1989;26:520A.
21. Edwards AD, Wyatt JS, Richardson C, et al. Effects of indometacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335:1491-5.
22. 141Xe Clearance. Pediatr Res 1991;30:570-3.
23. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennich RI. In: Dixon WJ, ed. BMDP Statistical Software Manual (vol 2). Berkeley: University of California Press, 1992.
24. Schluchter MD Analysis of incomplete multivariate data using linear models with structured covariance matrices. Statistics in Medicine 1988;7:317-24.
25. Draper N, Smith H. Applied regresion analysis. 2nd Edn. New York: John Wiley, 1981.
26. Cochran WG, Cox GM. Experimental designs. 2nd Edn. New York: John Willey, 1990.
27. Leahy FAN, Durand M, Cates D, Chernick V. Cranial blood volume changes during mechanical ventilation and spontaneous breathing in newborn infants. J Pediatr 1982;101:984-7.
28. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: A randomized, controlled trial. Pediatrics 1995;95:584-90.
29. 141xenon clearance. Pediatr Res 1990;27:445-9.
30. Brun NC, Greisen G. Cerebrovascular responses to carbon dioxide as detected by near-infrared spectrophotometry: Comparison of three different measures. Pediatr Res 1994;36:20-4.
31. Gardner DG, Have S, Trachevsky D, Schonk D, Baxter JD. Arterial natriuretic peptide mRNA is regulated by glucocorticoids in vivo. Biochem Biophys Res Commun 1986;139:1047-54.
32. Danaberg J, Gekiw RJ.Corticoid regulation of atrial natriuretic factor secretion and gene expression. Am J Physiol 1992;263:H1377-H181.
33. Demopoulos HB, Flamm ES, Pietronigro DD.The free radical pathology and microcirculation in the major central nervous system disorders. Acta Physiol Scand Suppl 1980;492:91-119.
34. Banglam AD, Standish MM, Weissmann G. The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol 1965;13:253-9.
35. Leviton A, Kuban KC, Pagano M, Allred EN, Van Marter L. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight babies. Pediatrics 1993;91:1083-8.
36. O'Shea M, Savitz DA, Hage ML, Feinstein KA. Prenatal events and the risk of subependymal/intraventricular hemorrhage in very low birth weight neonates. Paediatr Perinat Epidemiol 1992;6:352-62.
37. Garland JS, Buck R, Leviton A. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants. J Pediatr 1995;126:272-9.
38. Padbury JF, Polk DH, Hervin MG, Berri LM, Ikegami M, Jobe AH. Postnatal cardiovascular and metabolic responses to a single intramuscular dose of betamethasone in fetal sheep born prematurely by cesarean section. Pediatr Res 1995;38:709-15.
39. Volpe JJ. Intracranial hemorrhage: Germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe JJ, ed. Neurology of the newborn. 3rd Edn. Philadelphia: WB Saunders, 1995:403-63.